Cardiovascular
 
Dermatology
 
Endocrinology
 
Internal medicine
 
Medicine (General)
 
Head and neck
 
Immunology
 
Neurology
 
Oncology
 
Bone health
 
Pediatrics
 
Mental health
 
Respiratory medicine
 
Surgery
 
Veterinary medicine
 
Regional news
 
Most popular
 
Archive News

medwireNews Interviews
 
Friendly Links


Follow me on Twitter
IL-17A upregulated in pleural pathobiology
By Joanna Lyford, Senior medwireNews Reporter
02 January 2013
Respirol 2012; Advance online publication

medwireNews: The proinflammatory cytokine interleukin (IL)-17A is upregulated in pleural inflammation of bacterial origin and may be valuable as a diagnostic marker, study results indicate.

The findings are reported in Respirology by Ioannis Kalomenidis (National and Kapodistrian University of Athens, Haidari, Greece) and colleagues, who examined the role of IL-17A in a series of clinical and animal studies.

They began by measuring IL-17A expression in 84 patients with pleural effusions (PEs) of various etiologies. The cytokine was upregulated in several conditions, including in 62% of patients with pneumonia and in 40% of those with tuberculosis. It was less frequently upregulated in PEs of malignant (9%) or other etiologies (16%). Also, IL-17A was more often detected in the pleural fluid (32%) than in serum samples (10%).

In the same cohort, Kalomenidis measured levels of other markers of acute pleural inflammation, finding significant correlations between IL-17A and neutrophils, lactate dehydrogenase, glucose, pH, interleukin-8, and vascular endothelial growth factor.

The team then studied 92 patients with neutrophil-predominant PEs of various etiologies. In this cohort, IL-17A was upregulated in 46% of patients with pneumonia but in no other etiologic subtype.

Finally, the researchers injected IL-17A directly into the pleural space in mice. This resulted in a significant increase in pleural neutrophils at 4 and 24 hours post-injection, they report.

Furthermore, injection of anti-IL-17A neutralizing antibodies attenuated the inflammatory response to E. coli-derived lipopolysaccharide at 4 and 24 hours and to Staphylococcus aureus-induced pleural neutrophilia at 4 hours.

Kalomenidis and team conclude: "The central and novel message is the close association between IL-17A and pleural inflammation due to bacterial infection.

"The above findings suggest that IL-17A might be clinically useful as a diagnostic marker for parapneumonic pleural effusions and that IL-17A plays an important role in the pathobiology of infection-related pleural inflammation."

medwireNews (www.medwire-news.md) is an independent clinical news service provided by Springer Healthcare Limited. © Springer Healthcare Ltd; 2013

Free abstract

Comments
This article currently has no comments
Post a Comment

Please note, email address is required but not shown. Comments are moderated and will not appear until they have been approved. Please see the disclaimer for more information